OBJECTIVE: To examine the effect of HIV status on infants' mental and psychomotor functioning, controlling for confounding factors such as prenatal drug exposure and birth conditions. METHODS: Twenty HIV-infected and 25 seroreverted infants (ages 3-30 months old) were administered the Bayley Scales of Infant Development (BSID) and a neurological examination at two time points, 4 to 12 months apart. The majority were from ethnic minority, socioeconomically disadvantaged families; 67% of the infants were prenatally drug-exposed. RESULTS: HIV-infected infants had significantly lower scores on the BSID at baseline (mental development) and follow-up (motor development) compared to seroreverters. When HIV and neurological deficits were considered together, HIV+ children with neurological deficits scored significantly lower than HIV+ children without neurological deficits and seroreverters, with and without neurological diagnoses. Prenatal drug exposure was not associated with performance on the BSID. CONCLUSIONS: These data suggest that CNS involvement is a critical pathway by which HIV affects infants' neurodevelopment.
OBJECTIVE: To examine the effect of HIV status on infants' mental and psychomotor functioning, controlling for confounding factors such as prenatal drug exposure and birth conditions. METHODS: Twenty HIV-infected and 25 seroreverted infants (ages 3-30 months old) were administered the Bayley Scales of Infant Development (BSID) and a neurological examination at two time points, 4 to 12 months apart. The majority were from ethnic minority, socioeconomically disadvantaged families; 67% of the infants were prenatally drug-exposed. RESULTS:HIV-infectedinfants had significantly lower scores on the BSID at baseline (mental development) and follow-up (motor development) compared to seroreverters. When HIV and neurological deficits were considered together, HIV+ children with neurological deficits scored significantly lower than HIV+ children without neurological deficits and seroreverters, with and without neurological diagnoses. Prenatal drug exposure was not associated with performance on the BSID. CONCLUSIONS: These data suggest that CNS involvement is a critical pathway by which HIV affects infants' neurodevelopment.
Authors: Katherine S Elkington; Zachary Peters; C Jean Choi; Amelia Bucek; Cheng-Shiun Leu; Elaine J Abrams; Claude A Mellins Journal: AIDS Behav Date: 2018-10
Authors: Mia M Blakstad; Emily R Smith; Analee Etheredge; Lindsey M Locks; Christine M McDonald; Roland Kupka; Rodrick Kisenge; Said Aboud; David Bellinger; Christopher R Sudfeld; Wafaie W Fawzi; Karim Manji; Christopher P Duggan Journal: J Pediatr Date: 2018-12-14 Impact factor: 4.406
Authors: Allison Ross Eckard; Julia C Rosebush; Mary Ann O'Riordan; Chanda C Graves; Ashley Alexander; Anita K Grover; S Thera Lee; Jakob G Habib; Joshua H Ruff; Ann Chahroudi; Grace A McComsey Journal: Antivir Ther Date: 2017
Authors: Megan S McHenry; Carole I McAteer; Eren Oyungu; Brenna C McDonald; Chris B Bosma; Philani B Mpofu; Andrew R Deathe; Rachel C Vreeman Journal: Pediatrics Date: 2018-02 Impact factor: 7.124
Authors: Jose A Bauermeister; Katherine Elkington; Elizabeth Brackis-Cott; Curtis Dolezal; Claude Ann Mellins Journal: J Youth Adolesc Date: 2008-08-05
Authors: Thomas Struyf; Queen Dube; Elizabeth A Cromwell; Anna D Sheahan; Robert S Heyderman; Annelies Van Rie Journal: Eur J Paediatr Neurol Date: 2019-11-21 Impact factor: 3.140